Dr. Minggui Pan is a clinical associate professor at Stanford University School of Medicine. His research interest focuses on genomic alterations and cancer biology. He has authored more than 50 articles covering broad range of research areas, including the most recent article published in Journal of Clinical Oncology that revealed that the worse prognosis of metastatic right-sided colon cancer versus metastatic left-sided colorectal cancer was associated with TP53 non-gain-of-function mutations, while TP53 gain-of-function versus non-gain-function mutations were associated with worse prognosis of left-sided colorectal cancer but not right-sided colon cancer.